At what enterprise value was MEDNAX RADIOLOGY SOLUTIONS acquired in 2020?

You can find the full valuation details of MEDNAX RADIOLOGY SOLUTIONS on mynth capital. The transaction's Enterprise Value is estimated to be in the range of 500M - 1.5b EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 14.8x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of MEDNAX RADIOLOGY SOLUTIONS when it was acquired by RADIOLOGY PARTNERS?

The estimated EV/EBITDA multiple for MEDNAX RADIOLOGY SOLUTIONS is in the range of 5x - 12x. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 14.8x. Join our community for free to access full valuation data and industry trends.

What was the EBITDA of MEDNAX RADIOLOGY SOLUTIONS during the acquisition?

MEDNAX RADIOLOGY SOLUTIONS's EBITDA is estimated to be in the range of 50M - 100M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the MEDNAX RADIOLOGY SOLUTIONS acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the MEDNAX RADIOLOGY SOLUTIONS deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.radpartners.com/2020/12/radiology-partners-completes-acquisition-of-mednax-radiology-solutions/

← DATABASE

Home Database Healthcare & PharmaMEDNAX RADIOLOGY SOLUTIONS

12/2020

MEDNAX RADIOLOGY SOLUTIONS acquired by RADIOLOGY PARTNERS

UNITED STATES Health Providers / Outpatient Care / Radiology EV 500M - 1.5b EUR

Context

Radiology Partners has completed the acquisition of MEDNAX Radiology Solutions, bringing together two major players in the US radiology market to form a network of over 2,400 radiologists. This strategic move aims to enhance the combined entity's clinical capabilities, expand geographic coverage, and increase access to subspecialty expertise for partner healthcare institutions. The merger is also expected to facilitate the development of large-scale clinical programs and bolster investments in imaging technologies, digital solutions, and tools designed to improve the quality and efficiency of radiology services. Both organizations share a common goal of driving innovation in medical imaging and strengthening the role of radiology in patient care pathways. For Radiology Partners, this acquisition is part of a growth strategy focused on building a national platform to address the growing needs of healthcare systems for medical image interpretation. The integration of MEDNAX Radiology Solutions' teams is expected to leverage resources, broaden available expertise, and support the development of new clinical service models across the United States.

MEDNAX RADIOLOGY SOLUTIONS, which reported an EBITDA margin of LOGIN in 2020, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Healthcare & Pharma sector (14.8x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

MEDNAX Radiology Solutions is a leading US provider of specialized medical services. The business comprises a vast network of radiologists and medical imaging professionals serving hospitals, imaging centers, and other healthcare facilities across the United States. The division offers a comprehensive range of services spanning the full spectrum of diagnostic and interventional radiology, including image interpretation, teleradiology services, and subspecialty expertise. Its organizational structure enables seamless coverage of medical imaging needs while maintaining high clinical quality standards. MEDNAX Radiology Solutions also leverages the expertise of its parent company in managing specialized medical networks. The business relies on standardized clinical protocols, ongoing quality improvement initiatives, and technological tools designed to enhance the operational performance of radiology services. With its national network of practitioners and expertise in multiple imaging specialties, the division holds a significant position in the US radiology market. Its services play a critical role in providing essential diagnostic, therapeutic, and clinical decision-making support to numerous healthcare facilities.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2020

2019

Similar deals in Healthcare & Pharma

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
03/2021	TRITON PARTNERS	BERGMAN CLINICS	NETHERLANDS	Health Providers	Triton completed an investment in Bergman Clinics alongside existing shareholders NPM Capital and the Malenstein family, who both retained minority positions in the business. The transaction followed a competitive sale process mandated to JP Morgan and Axeco Corporate Finance, which attracted interest from TowerBrook Capital Partners, Cinven, Bain Capital, and BC Partners before Triton emerged as the winning bidder
02/2021	SILVER LAKE / NESTLE	IVC EVIDENSIA	UNITED KINGDOM	Health Providers	Silver Lake and Nestle led a EUR3.5 billion capital investment in IVC Evidensia, significantly increasing the group's valuation. The deal allowed EQT VII to partially exit its position, while EQT IX reinvested to remain the majority shareholder
12/2020	MEDIAN KLINIKEN	PRIORY GROUP	UNITED KINGDOM	Health Providers	MEDIAN Kliniken, a Waterland Private Equity portfolio company, agreed to acquire 100% of Priory Group from US-based Acadia Healthcare. Following closing, Waterland intends to combine Priory with MEDIAN to create a leading European rehabilitation and mental health services provider, operating 570 facilities and treating approximately 260,000 patients annually across the UK and Germany
12/2020	ANTIN INFRASTRUCTURE	HIPPOCRATES (LAF - LA FARMACIA)	ITALY	Health Providers	Antin Infrastructure Partners acquired a majority stake (approximately 80%) in Hippocrates Holding. The co-founders reinvested to retain the remaining 20% and maintained their roles as co-CEOs. The original investors (including DVR Capital and Italian family offices such as the Notarbartolo and Marzotto families) sold their shares in this transaction
12/2020	FRESENIUS	EUGIN GROUP	SPAIN	Health Providers	Fresenius Helios, the hospital and healthcare services division of Fresenius SE & Co. KGaA, acquired Eugin Group from NMC Health, a UAE-based listed healthcare group, through a dual acquisition structure targeting both the global ex-US operations (via Luarmia S.L...
11/2020	L CATTERTON	ALLIANCE ANIMAL HEALTH	UNITED STATES	Health Providers	L Catterton acquired a majority stake in Alliance Animal Health at a valuation up to $800M. The deal reflects the high demand for recession-resistant veterinary services. Under LightBay Capital's ownership (since June 2019), Alliance grew its EBITDA fivefold to reach $39M (pro forma adjusted)
11/2020	ARDIAN	INOVIE GROUP	FRANCE	Health Providers	Ardian led a consortium to acquire a minority stake (approx. 40% of financial rights) in Inovie. Due to French law (SEL), clinical biologists must retain the majority of voting rights and capital. The deal was designed to solve a "generational transition" problem, allowing ~130 older biologists to retire and cash out their shares while enabling younger biologists to buy in at normalized salary levels
11/2020	DWS GROUP	MEDIPASS	ITALY	Health Providers	DWS Alternatives Global Limited has acquired 100% of Medipass srl, a leading provider of cancer care and advanced diagnostic imaging services in Italy and the United Kingdom.
11/2020	ERGON CAPITAL PARTNERS	VIDACURA	GERMANY	Health Providers	Ergon Capital, acting through its acquisition vehicle SCUR-Alpha 1227 GmbH, acquired 100% of VidaCura's inpatient and ambulatory nursing care operations following clearance from the German Federal Cartel Office (Bundeskartellamt) on November 26, 2020
11/2020	MEDICA GROUP	GLOBAL DIAGNOSTICS	IRELAND	Health Providers	Global Diagnostics Ireland, which operates around 50 clinical centers across Ireland, has been acquired by Medica Group. For Medica, this acquisition represents a diversification of its customer base and geographic activities, as well as entry into a new market: ophthalmology and retinopathy screening

REFERENCES

Valuation range: EV 500M - 1.5b EUR

EBITDA range: 50M - 100M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of MEDNAX RADIOLOGY SOLUTIONS by RADIOLOGY PARTNERS are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Press release: view release

Acquirer: radiology partners